• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米配方白藜芦醇通过IL-6/JAK2/STAT3信号轴调节肿瘤相关巨噬细胞与癌症相关成纤维细胞之间的关联,从而抑制口腔癌细胞中的PD-L1。

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.

作者信息

Pradhan Rajalaxmi, Paul Subarno, Acharya Sushree Subhadra, Sinha Saptarshi, Dash Somya Ranjan, Kundu Chanakya Nath

机构信息

Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology, Deemed to be University, Bhubaneswar, Odisha, India.

Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology, Deemed to be University, Bhubaneswar, Odisha, India.

出版信息

J Nutr Biochem. 2024 Mar;125:109568. doi: 10.1016/j.jnutbio.2024.109568. Epub 2024 Jan 6.

DOI:10.1016/j.jnutbio.2024.109568
PMID:38185347
Abstract

Tumor associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) in the tumor microenvironment secrete several cytokines, which involved in tumor initiation, progression, metastatic outgrowth and angiogenesis. However, the association between TAMs and CAFs in the context of tumor development remain unclear. Here, we studied the relationship between TAMs and CAFs along with the involvement of cytokines in the production of cancer-stem-like-cells (CSCs) in oral cancer cells and explored the potential anticancer effects of Nano-formulated Resveratrol (Res-NP) using an activated macrophage-M1 (AM-M1) and activated fibroblast cells as the model system. IL-6 secretion was found to be enhanced in the conditioned-medium (CM) when AM-M1 cells + CAFs-like cells were cocultured together. CSCs-enriched population was developed after addition of CM of AM-M1 +CAFs in H-357 cells and patient-derived-primary-oral-cancer cells. AM-M1 cells+ CAFs-like cells secreted IL-6 enhanced CSCs growth, proliferation, metastasis, and angiogenesis. IL-6 was found to promote PD-L1 expression in CSCs-enriched cells via JAK2/STAT3 pathway, as evident from the enhanced expression of p-JAK2 and p-STAT3. Nevertheless, Res-NP inhibited CSCs proliferation and reduced the expression of metastatic and angiogenic markers, in ovo blood vascularization, NO production and MMPs expression. Res-NP delinked the association between AM-M1 and CAFs by blocking IL-6 production and also disrupted the potential connection between IL-6 and PD-L1 with considerable decrease in p-JAK2 and p-STAT3 expressions. IL-6 depletion inhibited stemness and angiogenesis in oral CSCs by downregulating PD-L1 via JAK2/STAT3 cascade. Similar observations were also observed in Res-NP treated xenograft mice. Thus, data demonstrate that CSCs growth is dependent on IL-6/PD-L1 axis. Res-NP deregulates the association between AM-M1 and CAFs along-with attenuates carcinogenesis in in vitro, in ovo, ex vivo and in vivo model systems by inhibiting PD-L1 via IL-6/JAK2/STAT3 axis.

摘要

肿瘤微环境中的肿瘤相关巨噬细胞(TAM)和癌症相关成纤维细胞(CAF)分泌多种细胞因子,这些细胞因子参与肿瘤的起始、进展、转移生长和血管生成。然而,在肿瘤发展过程中TAM与CAF之间的关联仍不清楚。在此,我们以活化的巨噬细胞M1(AM-M1)和活化的成纤维细胞为模型系统,研究了TAM与CAF之间的关系以及细胞因子在口腔癌细胞中癌干细胞样细胞(CSC)产生中的作用,并探讨了纳米制剂白藜芦醇(Res-NP)的潜在抗癌作用。当AM-M1细胞与CAF样细胞共培养时,发现条件培养基(CM)中的白细胞介素-6(IL-6)分泌增加。在H-357细胞和患者来源的原发性口腔癌细胞中加入AM-M1+CAF的CM后,富集了CSC的细胞群得以形成。AM-M1细胞+CAF样细胞分泌的IL-6促进了CSC的生长、增殖、转移和血管生成。发现IL-6通过JAK2/STAT3途径促进富集CSC的细胞中程序性死亡配体1(PD-L1)的表达,这从磷酸化JAK2(p-JAK2)和磷酸化STAT3(p-STAT3)表达的增加中可以明显看出。然而,Res-NP抑制了CSC的增殖,并降低了转移和血管生成标志物的表达、卵内血管生成、一氧化氮(NO)的产生和基质金属蛋白酶(MMP)的表达。Res-NP通过阻断IL-6的产生解除了AM-M1与CAF之间的关联,还破坏了IL-6与PD-L1之间的潜在联系,使p-JAK2和p-STAT3的表达显著降低。IL-6的消耗通过JAK2/STAT3级联下调PD-L1,从而抑制口腔CSC的干性和血管生成。在Res-NP处理的异种移植小鼠中也观察到了类似的结果。因此,数据表明CSC的生长依赖于IL-6/PD-L1轴。Res-NP通过IL-6/JAK2/STAT3轴抑制PD-L1,从而在体外、卵内、离体和体内模型系统中解除AM-M1与CAF之间的关联,并减弱致癌作用。

相似文献

1
Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.纳米配方白藜芦醇通过IL-6/JAK2/STAT3信号轴调节肿瘤相关巨噬细胞与癌症相关成纤维细胞之间的关联,从而抑制口腔癌细胞中的PD-L1。
J Nutr Biochem. 2024 Mar;125:109568. doi: 10.1016/j.jnutbio.2024.109568. Epub 2024 Jan 6.
2
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway.白藜芦醇纳米粒通过抑制 CXCL-12/IL-6 依赖性途径中的 CAFs 来下调炎症细胞因子,从而抑制口腔癌的转移和血管生成。
J Nutr Biochem. 2023 Mar;113:109257. doi: 10.1016/j.jnutbio.2022.109257. Epub 2022 Dec 24.
3
Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages.纳米制剂白藜芦醇通过靶向肿瘤相关巨噬细胞减少炎症细胞因子,从而抑制口腔癌细胞的转移和血管生成。
J Nutr Biochem. 2021 Jun;92:108624. doi: 10.1016/j.jnutbio.2021.108624. Epub 2021 Mar 8.
4
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.癌症相关成纤维细胞分泌的白细胞介素-6通过JAK2/STAT3信号通路促进胃癌的上皮-间质转化和转移。
Oncotarget. 2017 Mar 28;8(13):20741-20750. doi: 10.18632/oncotarget.15119.
5
Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.表皮调节素通过 JAK2-STAT3 通路重编程癌相关成纤维细胞,促进口腔鳞状细胞癌侵袭。
J Exp Clin Cancer Res. 2019 Jun 24;38(1):274. doi: 10.1186/s13046-019-1277-x.
6
Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.黑素瘤细胞分泌的外泌体 miR-155-5p 通过 SOCS1/JAK2/STAT3 信号通路诱导肿瘤相关成纤维细胞的促血管生成开关。
J Exp Clin Cancer Res. 2018 Oct 3;37(1):242. doi: 10.1186/s13046-018-0911-3.
7
Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.蒲公英提取物通过抑制 IL-10/STAT3/PD-L1 信号通路抑制肿瘤相关巨噬细胞微环境中三阴性乳腺癌细胞的恶性表型。
J Ethnopharmacol. 2021 Jun 28;274:113978. doi: 10.1016/j.jep.2021.113978. Epub 2021 Mar 11.
8
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.白细胞介素 6 通过降低人肝癌细胞中蛋白酪氨酸磷酸酶受体型 O 的表达促进单核细胞和巨噬细胞中 PD-L1 的表达。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000285.
9
M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.M1 样肿瘤相关巨噬细胞通过 IL6/Stat3/THBS1 反馈环级联口腔鳞状细胞癌的间充质/干细胞样表型。
J Exp Clin Cancer Res. 2022 Jan 6;41(1):10. doi: 10.1186/s13046-021-02222-z.
10
IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.白细胞介素-6/信号转导和转录激活因子3(IL-6/STAT3)轴通过上调基质金属蛋白酶组织抑制因子-1(TIMP-1)启动癌相关成纤维细胞(CAFs),而在肝癌微环境中,PCAF诱导的STAT3乙酰化减弱了这种作用。
Cell Signal. 2016 Sep;28(9):1314-1324. doi: 10.1016/j.cellsig.2016.06.009. Epub 2016 Jun 11.

引用本文的文献

1
The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets.癌症相关成纤维细胞与骨肉瘤细胞之间的恶性对话:微环境介导的耐药性及治疗靶点
Front Immunol. 2025 Aug 20;16:1621521. doi: 10.3389/fimmu.2025.1621521. eCollection 2025.
2
Resveratrol in oral cancer: a systematic review of preclinical studies on its anticancer mechanisms and therapeutic potential.白藜芦醇在口腔癌中的应用:对其抗癌机制和治疗潜力的临床前研究的系统综述
Med Oncol. 2025 Jul 13;42(8):329. doi: 10.1007/s12032-025-02903-1.
3
Cancer-associated Fibroblast-like Cells Promote Osteosarcoma Metastasis by Upregulation of Phosphoserine Aminotransferase 1 and Activation of the mTOR/S6K Pathway.
癌症相关成纤维细胞样细胞通过上调磷酸丝氨酸转氨酶1和激活mTOR/S6K信号通路促进骨肉瘤转移。
Int J Biol Sci. 2025 Jun 20;21(9):4153-4171. doi: 10.7150/ijbs.109169. eCollection 2025.
4
Oral squamous cell carcinoma: Insights into cellular heterogeneity, drug resistance, and evolutionary trajectories.口腔鳞状细胞癌:对细胞异质性、耐药性及进化轨迹的见解
Cell Biol Toxicol. 2025 Jun 12;41(1):101. doi: 10.1007/s10565-025-10048-0.
5
Natural anti-cancer products: insights from herbal medicine.天然抗癌产品:来自草药医学的见解。
Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y.
6
Integration of active ingredients from traditional Chinese medicine with nano-delivery systems for tumor immunotherapy.中药活性成分与纳米递送系统整合用于肿瘤免疫治疗
J Nanobiotechnology. 2025 May 17;23(1):357. doi: 10.1186/s12951-025-03378-y.
7
Deep insight into cytokine storm: from pathogenesis to treatment.深入洞察细胞因子风暴:从发病机制到治疗。
Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y.
8
Phytochemicals and their Nanoformulations for Overcoming Drug Resistance in Head and Neck Squamous Cell Carcinoma.用于克服头颈部鳞状细胞癌耐药性的植物化学物质及其纳米制剂
Pharm Res. 2025 Mar;42(3):429-449. doi: 10.1007/s11095-025-03836-0. Epub 2025 Mar 3.
9
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.PD-1/PD-L1信号轴在肿瘤发生中的作用及其被生物活性天然化合物靶向用于癌症免疫治疗的研究
Mil Med Res. 2024 Dec 18;11(1):82. doi: 10.1186/s40779-024-00586-9.
10
: Expression Patterns, Clinical Correlates and New Target of Papillary Thyroid Carcinoma.甲状腺乳头状癌的表达模式、临床关联及新靶点
J Cancer. 2024 Oct 21;15(19):6434-6451. doi: 10.7150/jca.98470. eCollection 2024.